Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hildesheim

Showing results (11-20 of 360) with videos related to

Pageof 36
Sort By:
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Comparison of benchtop microplate beta counters with the traditional gamma counting method for measurement of chromium-51 release in cytotoxic assaysDora Wallace, Allan Hildesheim, Ligia A Pinto
JAMA|June 19, 2014
Number of human papillomavirus vaccine doses and condylomaAimée R Kreimer, Mahboobeh Safaeian, Allan Hildesheim
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2020
Premature Years of Life Lost Due to Cancer in the United States in 2017Minkyo Song, Allan Hildesheim, Meredith S Shiels
Science Bulletin|December 13, 2023
Advances of biomarkers in nasopharyngeal carcinoma's early detectionXiao-Hui Zheng, Allan Hildesheim, Wei-Hua Jia
American Journal of Epidemiology|November 23, 2012
Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studiesAnil K Chaturvedi, Steven C Moore, Allan Hildesheim
Frontiers in Oncology|December 25, 2013
Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancersWen-Hui Su, Allan Hildesheim, Yu-Sun Chang
Cancer Epidemiology|February 4, 2018
Beasley's 1981 paper: The power of a well-designed cohort study to drive liver cancer research and preventionJill Koshiol, Zhiwei Liu, Thomas R O'Brien, et al.
Vaccine|September 5, 2006
Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccinesAllan Hildesheim, Lauri Markowitz, Mauricio Hernandez Avila, et al.
Lancet Regional Health. Americas|February 28, 2023
Excess mortality from COVID 19 in Costa Rica: a registry based study using Poisson regressionRomain Fantin, Cristina Barboza-Solís, Allan Hildesheim, et al.
Vaccine|July 18, 2006
Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccinationEduardo L Franco, Jack Cuzick, Allan Hildesheim, et al.
Pageof 36

Showing results (11-20 of 360) with videos related to

Sort By:
Pageof 36
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Comparison of benchtop microplate beta counters with the traditional gamma counting method for measurement of chromium-51 release in cytotoxic assaysDora Wallace, Allan Hildesheim, Ligia A Pinto
JAMA|June 19, 2014
Number of human papillomavirus vaccine doses and condylomaAimée R Kreimer, Mahboobeh Safaeian, Allan Hildesheim
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2020
Premature Years of Life Lost Due to Cancer in the United States in 2017Minkyo Song, Allan Hildesheim, Meredith S Shiels
Science Bulletin|December 13, 2023
Advances of biomarkers in nasopharyngeal carcinoma's early detectionXiao-Hui Zheng, Allan Hildesheim, Wei-Hua Jia
American Journal of Epidemiology|November 23, 2012
Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studiesAnil K Chaturvedi, Steven C Moore, Allan Hildesheim
Frontiers in Oncology|December 25, 2013
Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancersWen-Hui Su, Allan Hildesheim, Yu-Sun Chang
Cancer Epidemiology|February 4, 2018
Beasley's 1981 paper: The power of a well-designed cohort study to drive liver cancer research and preventionJill Koshiol, Zhiwei Liu, Thomas R O'Brien, et al.
Vaccine|September 5, 2006
Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccinesAllan Hildesheim, Lauri Markowitz, Mauricio Hernandez Avila, et al.
Lancet Regional Health. Americas|February 28, 2023
Excess mortality from COVID 19 in Costa Rica: a registry based study using Poisson regressionRomain Fantin, Cristina Barboza-Solís, Allan Hildesheim, et al.
Vaccine|July 18, 2006
Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccinationEduardo L Franco, Jack Cuzick, Allan Hildesheim, et al.
Pageof 36